The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...

Valneva has recieved Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya ...

First chikungunya vaccine recommended by the CHMP for persons as young as 12 years old.The virus-like particle (VLP) single-dose chikungunya vaccine is expected to launch in key European markets in ...

Pickleball's arrival in southeast Asia is diverting players away not just from tennis, but from badminton as well, long the ...

In a world where the consequences of climate change are increasingly evident, Pakistan must not only demand justice on the global stage but also provide its own citizens with much-needed climate ...

Specifically, Ixchiq will be tested in children aged one to 11 and pregnant women in countries that may be affected by a chikungunya outbreak, including Brazil, which is currently contending with ...

Recent outbreak of Guillain–Barré syndrome in Pune causing panic, symptoms, diagnosis, treatment, and prevention explained in ...

Valneva (VALN) stock gained as its chikungunya vaccine receives marketing authorization in the U.K., expanding the single-dose shot's global reach. Read more here.